Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
Go back to Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System| Stryker Corp. (NYSE: SYK) | Delayed: 330.69 +8.57 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.12 | 52 Week High | $123.55 | |||
| Open | $322.61 | 52 Week Low | $86.68 | |||
| Day High | $332.72 | P/E | 125.74 | |||
| Day Low | $322.12 | EPS | $2.63 | |||
| Volume | 2,227,794 | |||||
